Target intelligence / Profile preview

ADP-ribosylation factor 6 regulatory protein (Arf6 regulatory protein)

Target
Arf6 regulatory protein
Molecular classification
Enzyme, Signaling protein, Guanine nucleotide exchange factor, GTPase-activating protein
01

Overview

ADP-ribosylation factor 6 (Arf6) regulatory proteins are a specialized group of enzymes that control the activity of the Arf6 GTPase, a key regulator of membrane trafficking and actin dynamics at the cell periphery (Casanova, 2007). This group primarily consists of Guanine Nucleotide Exchange Factors (GEFs), such as the cytohesin and EFA6 families, which activate Arf6 by promoting the exchange of GDP for GTP, and GTPase-Activating Proteins (GAPs), such as the ACAP and GIT families, which return Arf6 to its inactive GDP-bound state (D'Souza-Schorey & Chavrier, 2006). These regulators are critical for processes including endocytosis, exocytosis, and cell migration, making them pivotal in physiological signaling. In disease contexts, overactivation of Arf6 by its GEFs is frequently associated with cancer metastasis, tumor invasion, and pathological angiogenesis (Li et al., 2017). Pharmacological intervention often targets the GEFs; for instance, the small molecule SecinH3 inhibits the cytohesin family of GEFs, thereby blocking Arf6 activation and reducing tumor growth in experimental models (Hafner et al., 2006). Additionally, inhibitors like NAV-2729 have been developed to disrupt the interaction between Arf6 and its regulatory GEFs to treat conditions like uveal melanoma and diabetic retinopathy (Yoo et al., 2016).

Other names
Arf6 GEFsArf6 GAPsArf6 regulatorsADP-ribosylation factor 6 guanine nucleotide exchange factorsADP-ribosylation factor 6 GTPase-activating proteins
02

Mechanism of action

Inhibition of guanine nucleotide exchange factor (GEF) activity to prevent Arf6 activation or modulation of GTPase-activating protein (GAP) activity.

03

Biological functions

Vesicular traffickingActin cytoskeleton remodelingEndocytosisExocytosisCell migrationSignal transduction
04

Disease associations

CancerInflammationInfectionCardiovascular diseaseDiabetic retinopathy
05

Safety considerations

Potential for broad toxicity due to essential roles in membrane traffickingOff-target inhibition of other Arf family membersDisruption of normal immune cell function
06

Interacting drugs

SecinH3

2 more in the full profile.

07

Biomarkers

Arf6-GTP levelsPhospho-ERK1/2E-cadherin internalization

Beyond the preview

Go deeper on ADP-ribosylation factor 6 regulatory protein (Arf6 regulatory protein).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ADP-ribosylation factor 6 regulatory protein (Arf6 regulatory protein).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call